+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hysterectomy Device Market By Disease type, By Surgical approach, By End User: Global Opportunity Analysis and Industry Forecast, 2022-2031

  • PDF Icon

    Report

  • 389 Pages
  • August 2023
  • Region: Global
  • Allied Market Research
  • ID: 5781768
The global hysterectomy device market was valued at $328.09 million in 2021 and is projected to reach $566.5 million by 2031, registering a CAGR of 5.63% from 2022 to 2031.
The surgical removal of the uterus and, less frequently, the cervix is known as a hysterectomy. A hysterectomy may involve the removal of nearby organs and tissues, including the ovaries and fallopian tubes, depending on the reason for the surgery. It is typically performed as a treatment for a variety of gynecological conditions, such as uterine fibroids, endometriosis, and abnormal uterine bleeding. Hysterectomy can be performed using a variety of surgical techniques, including open surgery, laparoscopic surgery, and robot-assisted surgery.

The driving factors for hysterectomy device market is rise in prevalence of uterine cancer. Uterine cancer is one of the most common gynecological cancers, and hysterectomy is a common treatment option for this disease. In addition, various government organizations and NGOs are creating awareness among the people about women’s health which also fuels the market growth. Moreover, hysterectomy devices have seen a number of technological advancements in recent years, which have improved surgical outcomes, decreased patient discomfort and recovery time also propels the market growth.

However, factors such as availability of alternative treatment for the treatment of gynecological disorders expected to hinder the growth of hysterectomy device market. On the other hand, a surge in demand for minimally or less invasive surgeries is anticipated to offer growth opportunity for the market.

The global hysterectomy device market is segmented into disease type, surgical approach, end user and region. By disease type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic assisted laparoscopic hysterectomy and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major Key players that operate in the global hysterectomy device market are Conkin surgical instruments ltd, Cooper Surgical, B. braun medical ltd, KARL STORZ GmbH & Co. KG, Conmed Corporation, Jhonson & Jhonson, Richard Wolf GmbH, Fortimedix Surgical, Medtronic corporation and Laborie, Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hysterectomy device market analysis from 2021 to 2031 to identify the prevailing hysterectomy device market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the hysterectomy device market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global hysterectomy device market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly update (only available with the purchase of an enterprise license)
  • 5 additional company profiles of your choice, pre- or post-purchase, as a free update.
  • Free updated version (once released) with the purchase of a 1-5 or enterprise user license.
  • 16 analyst hours of support (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% free customization (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
  • Free data pack (Excel version) with the purchase of a 1-5 or enterprise user license.
  • Free report update, if the report is 6-12 months old or older.
  • 24-hour priority response
  • Free industry updates and white papers.

Key Market Segments

By Surgical approach

  • Laparoscopic hysterectomy
  • Robotic assisted laparoscopic hysterectomy
  • Abdominal hysterectomy
  • Vaginal hysterectomy

By Disease type

  • Uterine Cancer
  • Fibroids
  • Chronic pelvic pain
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • B. Braun Melsungen AG
  • Conkin surgical instruments ltd
  • CONMED Corporation
  • Cooper Companies, Inc.
  • fortimedix surgical b.v.
  • Johnson & Johnson
  • KARL STORZ GmbH & Co. KG
  • Laborie, Inc
  • Medtronic plc
  • Richard Wolf GmbH

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate threat of substitutes
3.3.2. Moderate intensity of rivalry
3.3.3. High bargaining power of buyers
3.3.4. High bargaining power of suppliers
3.3.5. Moderate threat of new entrants
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of uterine cancer
3.4.1.2. Increase in awareness of women’s health
3.4.1.3. Technological advancements in hysterectomy devices
3.4.2. Restraints
3.4.2.1. Availability of alternative treatments
3.4.3. Opportunities
3.4.3.1. Increase in demand for the minimally invasive procedures
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Uterine Cancer
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Fibroids
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Chronic pelvic pain
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Others
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH
5.1. Overview
5.1.1. Market size and forecast
5.2. Vaginal hysterectomy
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Laparoscopic hysterectomy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Robotic assisted laparoscopic hysterectomy
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Abdominal hysterectomy
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: HYSTERECTOMY DEVICE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory Surgical Centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: HYSTERECTOMY DEVICE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Disease type
7.2.3. Market size and forecast, by Surgical approach
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Disease type
7.2.5.1.3. Market size and forecast, by Surgical approach
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Disease type
7.2.5.2.3. Market size and forecast, by Surgical approach
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Disease type
7.2.5.3.3. Market size and forecast, by Surgical approach
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Disease type
7.3.3. Market size and forecast, by Surgical approach
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Disease type
7.3.5.1.3. Market size and forecast, by Surgical approach
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Disease type
7.3.5.2.3. Market size and forecast, by Surgical approach
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Disease type
7.3.5.3.3. Market size and forecast, by Surgical approach
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Disease type
7.3.5.4.3. Market size and forecast, by Surgical approach
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Disease type
7.3.5.5.3. Market size and forecast, by Surgical approach
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Disease type
7.3.5.6.3. Market size and forecast, by Surgical approach
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Disease type
7.4.3. Market size and forecast, by Surgical approach
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Disease type
7.4.5.1.3. Market size and forecast, by Surgical approach
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Disease type
7.4.5.2.3. Market size and forecast, by Surgical approach
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Disease type
7.4.5.3.3. Market size and forecast, by Surgical approach
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Disease type
7.4.5.4.3. Market size and forecast, by Surgical approach
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Disease type
7.4.5.5.3. Market size and forecast, by Surgical approach
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Disease type
7.4.5.6.3. Market size and forecast, by Surgical approach
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Disease type
7.5.3. Market size and forecast, by Surgical approach
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Disease type
7.5.5.1.3. Market size and forecast, by Surgical approach
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Disease type
7.5.5.2.3. Market size and forecast, by Surgical approach
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Disease type
7.5.5.3.3. Market size and forecast, by Surgical approach
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Disease type
7.5.5.4.3. Market size and forecast, by Surgical approach
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Conkin surgical instruments ltd
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. KARL STORZ GmbH & Co. KG
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. CONMED Corporation
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Richard Wolf GmbH
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. fortimedix surgical b.v.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Johnson & Johnson
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Laborie, Inc
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Cooper Companies, Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. B. Braun Melsungen AG
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Medtronic plc
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
List of Tables
Table 01. Global Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 02. Hysterectomy Device Market for Uterine Cancer, by Region, 2021-2031 ($Million)
Table 03. Hysterectomy Device Market for Fibroids, by Region, 2021-2031 ($Million)
Table 04. Hysterectomy Device Market for Chronic Pelvic Pain, by Region, 2021-2031 ($Million)
Table 05. Hysterectomy Device Market for Others, by Region, 2021-2031 ($Million)
Table 06. Global Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 07. Hysterectomy Device Market for Vaginal Hysterectomy, by Region, 2021-2031 ($Million)
Table 08. Hysterectomy Device Market for Laparoscopic Hysterectomy, by Region, 2021-2031 ($Million)
Table 09. Hysterectomy Device Market for Robotic Assisted Laparoscopic Hysterectomy, by Region, 2021-2031 ($Million)
Table 10. Hysterectomy Device Market for Abdominal Hysterectomy, by Region, 2021-2031 ($Million)
Table 11. Global Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 12. Hysterectomy Device Market for Hospitals, by Region, 2021-2031 ($Million)
Table 13. Hysterectomy Device Market for Ambulatory Surgical Centers, by Region, 2021-2031 ($Million)
Table 14. Hysterectomy Device Market for Others, by Region, 2021-2031 ($Million)
Table 15. Hysterectomy Device Market, by Region, 2021-2031 ($Million)
Table 16. North America Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 17. North America Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 18. North America Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 19. North America Hysterectomy Device Market, by Country, 2021-2031 ($Million)
Table 20. U.S. Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 21. U.S. Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 22. U.S. Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 23. Canada Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 24. Canada Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 25. Canada Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 26. Mexico Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 27. Mexico Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 28. Mexico Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 29. Europe Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 30. Europe Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 31. Europe Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 32. Europe Hysterectomy Device Market, by Country, 2021-2031 ($Million)
Table 33. Germany Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 34. Germany Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 35. Germany Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 36. France Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 37. France Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 38. France Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 39. UK Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 40. UK Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 41. UK Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 42. Italy Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 43. Italy Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 44. Italy Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 45. Spain Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 46. Spain Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 47. Spain Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 48. Rest of Europe Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 49. Rest of Europe Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 50. Rest of Europe Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 51. Asia-Pacific Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 52. Asia-Pacific Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 53. Asia-Pacific Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 54. Asia-Pacific Hysterectomy Device Market, by Country, 2021-2031 ($Million)
Table 55. Japan Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 56. Japan Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 57. Japan Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 58. China Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 59. China Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 60. China Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 61. India Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 62. India Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 63. India Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 64. Australia Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 65. Australia Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 66. Australia Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 67. South Korea Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 68. South Korea Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 69. South Korea Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 70. Rest of Asia-Pacific Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 71. Rest of Asia-Pacific Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 72. Rest of Asia-Pacific Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 73. LAMEA Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 74. LAMEA Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 75. LAMEA Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 76. LAMEA Hysterectomy Device Market, by Country, 2021-2031 ($Million)
Table 77. Brazil Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 78. Brazil Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 79. Brazil Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 80. Saudi Arabia Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 81. Saudi Arabia Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 82. Saudi Arabia Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 83. South Africa Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 84. South Africa Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 85. South Africa Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 86. Rest of LAMEA Hysterectomy Device Market, by Disease Type, 2021-2031 ($Million)
Table 87. Rest of LAMEA Hysterectomy Device Market, by Surgical Approach, 2021-2031 ($Million)
Table 88. Rest of LAMEA Hysterectomy Device Market, by End-user, 2021-2031 ($Million)
Table 89. Conkin Surgical Instruments Ltd.: Key Executives
Table 90. Conkin Surgical Instruments Ltd.: Company Snapshot
Table 91. Conkin Surgical Instruments Ltd.: Product Segments
Table 92. Conkin Surgical Instruments Ltd.: Product Portfolio
Table 93. Karl Storz GmbH & Co. KG: Key Executives
Table 94. Karl Storz GmbH & Co. KG: Company Snapshot
Table 95. Karl Storz GmbH & Co. KG: Product Segments
Table 96. Karl Storz GmbH & Co. KG: Product Portfolio
Table 97. Conmed Corporation: Key Executives
Table 98. Conmed Corporation: Company Snapshot
Table 99. Conmed Corporation: Product Segments
Table 100. Conmed Corporation: Product Portfolio
Table 101. Richard Wolf GmbH: Key Executives
Table 102. Richard Wolf GmbH: Company Snapshot
Table 103. Richard Wolf GmbH: Product Segments
Table 104. Richard Wolf GmbH: Product Portfolio
Table 105. Fortimedix Surgical B.V.: Key Executives
Table 106. Fortimedix Surgical B.V.: Company Snapshot
Table 107. Fortimedix Surgical B.V.: Product Segments
Table 108. Fortimedix Surgical B.V.: Product Portfolio
Table 109. Johnson & Johnson: Key Executives
Table 110. Johnson & Johnson: Company Snapshot
Table 111. Johnson & Johnson: Product Segments
Table 112. Johnson & Johnson: Product Portfolio
Table 113. Laborie, Inc.: Key Executives
Table 114. Laborie, Inc.: Company Snapshot
Table 115. Laborie, Inc.: Product Segments
Table 116. Laborie, Inc.: Product Portfolio
Table 117. Cooper Companies, Inc.: Key Executives
Table 118. Cooper Companies, Inc.: Company Snapshot
Table 119. Cooper Companies, Inc.: Product Segments
Table 120. Cooper Companies, Inc.: Product Portfolio
Table 121. Cooper Companies, Inc.: Key Stratergies
Table 122. B. Braun Melsungen AG: Key Executives
Table 123. B. Braun Melsungen AG: Company Snapshot
Table 124. B. Braun Melsungen AG: Product Segments
Table 125. B. Braun Melsungen AG: Product Portfolio
Table 126. Medtronic PLC: Key Executives
Table 127. Medtronic PLC: Company Snapshot
Table 128. Medtronic PLC: Product Segments
Table 129. Medtronic PLC: Product Portfolio
List of Figures
Figure 01. Hysterectomy Device Market, 2021-2031
Figure 02. Segmentation of Hysterectomy Device Market, 2021-2031
Figure 03. Hysterectomy Device Market, 2021-2031
Figure 04. Top Investment Pockets in Hysterectomy Device Market (2022-2031)
Figure 05. Moderate Threat of Substitutes
Figure 06. Moderate Intensity of Rivalry
Figure 07. High Bargaining Power of Buyers
Figure 08. High Bargaining Power of Suppliers
Figure 09. Moderate Threat of New Entrants
Figure 10. Global Hysterectomy Device Market:Drivers, Restraints and Opportunities
Figure 11. Hysterectomy Device Market, by Disease Type, 2021 (%)
Figure 12. Comparative Share Analysis of Hysterectomy Device Market for Uterine Cancer, by Country 2021 and 2031 (%)
Figure 13. Comparative Share Analysis of Hysterectomy Device Market for Fibroids, by Country 2021 and 2031 (%)
Figure 14. Comparative Share Analysis of Hysterectomy Device Market for Chronic Pelvic Pain, by Country 2021 and 2031 (%)
Figure 15. Comparative Share Analysis of Hysterectomy Device Market for Others, by Country 2021 and 2031 (%)
Figure 16. Hysterectomy Device Market, by Surgical Approach, 2021 (%)
Figure 17. Comparative Share Analysis of Hysterectomy Device Market for Vaginal Hysterectomy, by Country 2021 and 2031 (%)
Figure 18. Comparative Share Analysis of Hysterectomy Device Market for Laparoscopic Hysterectomy, by Country 2021 and 2031 (%)
Figure 19. Comparative Share Analysis of Hysterectomy Device Market for Robotic Assisted Laparoscopic Hysterectomy, by Country 2021 and 2031 (%)
Figure 20. Comparative Share Analysis of Hysterectomy Device Market for Abdominal Hysterectomy, by Country 2021 and 2031 (%)
Figure 21. Hysterectomy Device Market, by End-user, 2021 (%)
Figure 22. Comparative Share Analysis of Hysterectomy Device Market for Hospitals, by Country 2021 and 2031 (%)
Figure 23. Comparative Share Analysis of Hysterectomy Device Market for Ambulatory Surgical Centers, by Country 2021 and 2031 (%)
Figure 24. Comparative Share Analysis of Hysterectomy Device Market for Others, by Country 2021 and 2031 (%)
Figure 25. Hysterectomy Device Market by Region, 2021
Figure 26. U.S. Hysterectomy Device Market, 2021-2031 ($Million)
Figure 27. Canada Hysterectomy Device Market, 2021-2031 ($Million)
Figure 28. Mexico Hysterectomy Device Market, 2021-2031 ($Million)
Figure 29. Germany Hysterectomy Device Market, 2021-2031 ($Million)
Figure 30. France Hysterectomy Device Market, 2021-2031 ($Million)
Figure 31. UK Hysterectomy Device Market, 2021-2031 ($Million)
Figure 32. Italy Hysterectomy Device Market, 2021-2031 ($Million)
Figure 33. Spain Hysterectomy Device Market, 2021-2031 ($Million)
Figure 34. Rest of Europe Hysterectomy Device Market, 2021-2031 ($Million)
Figure 35. Japan Hysterectomy Device Market, 2021-2031 ($Million)
Figure 36. China Hysterectomy Device Market, 2021-2031 ($Million)
Figure 37. India Hysterectomy Device Market, 2021-2031 ($Million)
Figure 38. Australia Hysterectomy Device Market, 2021-2031 ($Million)
Figure 39. South Korea Hysterectomy Device Market, 2021-2031 ($Million)
Figure 40. Rest of Asia-Pacific Hysterectomy Device Market, 2021-2031 ($Million)
Figure 41. Brazil Hysterectomy Device Market, 2021-2031 ($Million)
Figure 42. Saudi Arabia Hysterectomy Device Market, 2021-2031 ($Million)
Figure 43. South Africa Hysterectomy Device Market, 2021-2031 ($Million)
Figure 44. Rest of LAMEA Hysterectomy Device Market, 2021-2031 ($Million)
Figure 45. Top Winning Strategies, by Year
Figure 46. Top Winning Strategies, by Development
Figure 47. Top Winning Strategies, by Company
Figure 48. Product Mapping of Top 10 Players
Figure 49. Competitive Dashboard
Figure 50. Competitive Heatmap: Hysterectomy Device Market
Figure 51. Top Player Positioning, 2021
Figure 52. Conmed Corporation.: Net Sales, 2020-2022 ($Million)
Figure 53. Conmed Corporation.: Revenue Share by Segment, 2022 (%)
Figure 54. Conmed Corporation.: Revenue Share by Region, 2022 (%)
Figure 55. Johnson & Johnson: Net Sales, 2020-2022 ($Million)
Figure 56. Johnson & Johnson: Revenue Share by Segment, 2022 (%)
Figure 57. Johnson & Johnson: Revenue Share by Region, 2022 (%)
Figure 58. Cooper Companies, Inc.: Net Revenue, 2020-2022 ($Million)
Figure 59. Cooper Companies, Inc.: Revenue Share by Segment, 2022 (%)
Figure 60. B. Braun Melsungen AG: Net Sales, 2020-2022 ($Million)
Figure 61. B. Braun Melsungen AG: Revenue Share by Region, 2022 (%)
Figure 62. B. Braun Melsungen AG: Revenue Share by Segment, 2022 (%)
Figure 63. Medtronic PLC: Net Sales, 2020-2022 ($Million)
Figure 64. Medtronic PLC: Revenue Share by Segment, 2022 (%)
Figure 65. Medtronic PLC: Revenue Share by Region, 2022 (%)

Executive Summary

According to this report, the hysterectomy device market was valued at $328.09 million in 2021, and is estimated to reach $566.5 million by 2031, growing at a CAGR of 5.6% from 2022 to 2031.

Hysterectomy device s are used to perform hysterectomy surgeries which involve removal of uterus and around organs due to uterine cancer, fibroids, chronic pelvic pain, uterine prolapse, endometriosis and adenomyosis. These device s are designed to help surgeons safely and effectively remove the uterus and associated tissue while minimizing complications and reducing patient recovery time. A hysterectomy may involve the removal of nearby organs and tissues, including the ovaries and fallopian tubes, depending on the purpose of surgery.

Key factors driving the growth of the hysterectomy device market include rise in prevalence of cancer disease especially uterine cancer led to increases the number of patients who needs a diagnosis and treatment which increased the adoption of hysterectomy procedure for treatment purpose supports the market growth. The most prevalent type of gynecological cancer, uterine cancer, affects women of all ages. Uterine cancer risk rises with age, and women over 50 are more likely to be diagnosed with the condition.

Hysterectomy is also used to treat other gynecologic disorders like endometriosis, uterine fibroids, and irregular uterine bleeding in addition to uterine cancer. Moreover rising prevalence of fibroids and demand for hysterectomy for treatment of the fibroids propels the market growth. For an instance, according to the U. S. Department of the Health & Human Services More than 200,000 hysterectomies are performed each year for uterine fibroids.

In addition, growing awareness of women's health is one of the key drivers of the hysterectomy devices market. Various organizations are carrying out campaigns to rise awareness among women related to gynecological health. Furthermore, the market for hysterectomy devices has grown significantly owing to technological improvements. The procedure is now less invasive and has a shorter recovery period because of advances in minimally invasive surgical procedures including laparoscopic and robot-assisted hysterectomy. Moreover, the market for hysterectomy devices is expected to grow during the forecast period as a result of the rising focus on women's health and the availability of more cutting-edge, minimally invasive treatment alternatives.

Some gynecologic diseases can be effectively treated by hysterectomy. It is a significant surgical treatment with potential risks and long-term effects, including menopause and infertility. As a result, the availability of alternative treatments may hinder the market growth for hysterectomy devices as patients choose less invasive procedures like hormone therapy or uterine artery embolization that may also result in quicker recovery times. Conversely, the market is anticipated to experience growth during the forecast period as a result of the rising demand for minimally invasive procedures and robotic-assisted surgeries. Due to their potential advantages, such as shorter hospital stays, less blood loss, and quicker recovery times when compared to conventional open surgery.

The global hysterectomy device market is segmented into disease type, surgical approach, end user and region. By disease type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic assisted laparoscopic hysterectomy and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center and others. Region wise, the market is analyzed across North America (the U. S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The key players profiled in the study include Conkin surgical instruments ltd, Cooper Surgical, B. braun medical ltd, KARL STORZ GmbH & Co. KG, Conmed Corporation, Jhonson & Jhonson, Richard Wolf GmbH, Fortimedix Surgical, Medtronic corporation and Laborie, Inc. The players in the market have been actively engaged in the adoption various strategies such as acquisition to remain competitive and gain advantage over the competitors in the market. For instance, in May 2020, in February 2022, Cooper Companies announced it has signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets.

Key Market Insights (Updated)
By disease type, the chronic pelvic pain segment was the largest revenue contributor to the market in 2021. However, the fibroids segment is anticipated to grow at the highest CAGR during the forecast period.

By surgical approach, the abdominal hysterectomy segment dominated the global market in 2021.

Based on end user, the hospital segment was the largest revenue contributor to the market in 2021 and is estimated to reach $261.8 million by 2031, with a CAGR of 5.9%.

Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • B. Braun Melsungen AG
  • Conkin surgical instruments ltd
  • CONMED Corporation
  • Cooper Companies, Inc.
  • fortimedix surgical b.v.
  • Johnson & Johnson
  • KARL STORZ GmbH & Co. KG
  • Laborie, Inc
  • Medtronic plc
  • Richard Wolf GmbH

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...